Inversago Pharma to Participate at the 2023 SVB Securities Global Biopharma Conference
Inversago Pharma Inc. (“Inversago”), a clinical stage biotech company with a unique portfolio of peripherally-acting CB1 inverse agonists, today announced that François Ravenelle, Ph.D., Chief Executive Officer, and Glenn Vraniak, MBA, Chief Financial Officer, will host investor meetings during the Private Company Exhibition at the 2023 SVB Securities Global Biopharma Conference being held January 31 through February 2, 2023.
For additional information or to request a meeting with management, please contact conference representatives.
About Inversago Pharma
Inversago Pharma is a privately owned, clinical stage, Canadian biotech company, specialized in the development of new therapies focusing on CB1 blockade, based on first-in-class, peripherally-acting CB1 inverse agonists. Inversago aims to provide new treatment options that improve the lives of patients affected by metabolic conditions such as diabetic kidney disease (DKD), including diabetic nephropathy (DN), type 1 and type 2 diabetes (T1D / T2D), non-alcoholic steatohepatitis (NASH), complications of obesity and hypertriglyceridemia (HTG), as well as fibrotic indications like progressive fibrosis-interstitial lung disease (PF-ILD), including idiopathic pulmonary fibrosis (IPF) and other conditions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
DEXLEVO3.2.2023 09:16:42 CET | Press release
Dexlevo’s GOURI Symposium and Brand Event at IMCAS 2023
PAYRETAILERS3.2.2023 09:01:36 CET | Press release
PayRetailers Appoints Lorenzo Pellegrino as New Chief Operating & Digital Officer
XPENG-MOTORS3.2.2023 08:01:41 CET | Press release
XPENG Launches G9 SUV and P7 Sedan for Europe
OH-WESTFIELD/LLOYD’S2.2.2023 22:19:37 CET | Press release
Westfield Completes Acquisition of Lloyd’s of London Syndicate 1200
TX-GEOSWIFT2.2.2023 21:17:35 CET | Press release
Mobile Commerce Platform Fintiv Partners with Geoswift to Enable Cross-border Digital Remittance in Asia
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom